
CAS 1791420-09-1
:Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
2 produtos.
Dilpacimab
CAS:A humanized dual-variable domain antibody targets both delta-like ligand 4 (DLL4) and VEGF pathwaysDilpacimab
CAS:Dilpacimab (ABT165) is a dual-variable antibody that targets DLL4 and VEGF pathways, showing potential in cancer research by blocking angiogenesis and Notch.Pureza:95% - 97.7% (SDS-PAGE); 95.6% (SEC-HPLC)Cor e Forma:Liquid


